{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:32:52Z","timestamp":1792834372794,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11360-y","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T06:36:27Z","timestamp":1765434987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dual role of Curcumin and nano-formulations in radiotherapy: sensitizing cancer cells and protecting normal cells"],"prefix":"10.1007","volume":"53","author":[{"given":"Mohammad Taghi","family":"Bahreyni Toossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Gholamhoseinian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Azimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Reza","family":"Jaafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad Sahab","family":"Negah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3207-0850","authenticated-orcid":false,"given":"Elham","family":"Dolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"issue":"Suppl","key":"11360_CR1","first-page":"37","volume":"6","author":"M Rezaei-Tavirani","year":"2013","unstructured":"Rezaei-Tavirani M et al (2013) TiO2 nanoparticle as a sensitizer drug in radiotherapy: in vitro study. Iran J Cancer Prev 6(Suppl):37\u201344","journal-title":"Iran J Cancer Prev"},{"issue":"4","key":"11360_CR2","first-page":"223","volume":"20","author":"E Dolat","year":"2013","unstructured":"Dolat E et al (2013) Evaluation of synergistic effect of TiO2 nanoparticles and gamma rays on human breast cancer cell line. J Ilam Univ Med Sci 20(4):223\u2013230","journal-title":"J Ilam Univ Med Sci"},{"issue":"6","key":"11360_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4103\/jmss.jmss_40_23","volume":"14","author":"MT Bahreyni Toosi","year":"2024","unstructured":"Bahreyni Toosi MT et al (2024) Evaluation of relationship between intrinsic radiosensitivity (Survival fraction at 2 Gy) and Gamma-H2AX test and apoptosis of lymphocytes in breast cancer patients. J Med Signals Sens 14(6):17","journal-title":"J Med Signals Sens"},{"issue":"null","key":"11360_CR4","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.2147\/IJN.S290438","volume":"16","author":"L Gong","year":"2021","unstructured":"Gong L et al (2021) Application of radiosensitizers in cancer radiotherapy. Int J Nanomed 16(null):1083\u20131102","journal-title":"Int J Nanomed"},{"issue":"1","key":"11360_CR5","doi-asserted-by":"publisher","first-page":"e10256","DOI":"10.1002\/btm2.10256","volume":"7","author":"C Bilynsky","year":"2022","unstructured":"Bilynsky C, Millot N, Papa A-L (2022) Radiation nanosensitizers in cancer therapy\u2014From preclinical discoveries to the outcomes of early clinical trials. Bioeng Translational Med 7(1):e10256","journal-title":"Bioeng Translational Med"},{"key":"11360_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810627","volume":"23","author":"D Komorowska","year":"2022","unstructured":"Komorowska D et al (2022) Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol. Int J Mol Sci 23:10627. https:\/\/doi.org\/10.3390\/ijms231810627","journal-title":"Int J Mol Sci"},{"issue":"3","key":"11360_CR7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.22038\/ijbms.2019.32873.7852","volume":"22","author":"M Hatamipour","year":"2019","unstructured":"Hatamipour M et al (2019) Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids. Iran J Basic Med Sci 22(3):282. https:\/\/doi.org\/10.22038\/ijbms.2019.32873.7852","journal-title":"Iran J Basic Med Sci"},{"issue":"10","key":"11360_CR8","first-page":"2376","volume":"11","author":"A Giordano","year":"2019","unstructured":"Giordano A, Tommonaro G (2019) Curcumin Cancer Nutrients 11(10):2376","journal-title":"Curcumin Cancer Nutrients"},{"issue":"8","key":"11360_CR9","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/sj.onc.1207284","volume":"23","author":"D Chendil","year":"2004","unstructured":"Chendil D et al (2004) Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 23(8):1599\u20131607","journal-title":"Oncogene"},{"key":"11360_CR10","first-page":"2601","volume":"7","author":"H-s Shi","year":"2012","unstructured":"Shi H-s et al (2012) A systemic administration of liposomal Curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation. Int J Nanomed 7:2601","journal-title":"Int J Nanomed"},{"key":"11360_CR11","doi-asserted-by":"publisher","DOI":"10.2174\/0115680096360434250211042759","author":"E Raeisi","year":"2025","unstructured":"Raeisi E, Heidari-Soureshjani S, Mt Sherwin C, Lemoigne Y, Nafchi HM (2025) Advances in Radiation Therapy Enhancement and Radio-Protection by Nano-Curcumins: A Systematic Review. Curr Cancer Drug Targets. https:\/\/doi.org\/10.2174\/0115680096360434250211042759","journal-title":"Curr Cancer Drug Targets"},{"key":"11360_CR12","first-page":"405","volume":"18","author":"F Yousefi","year":"2019","unstructured":"Yousefi F et al (2019) Immunoregulatory, proliferative and anti-oxidant effects of nanocurcuminoids on adipose-derived mesenchymal stem cells. EXCLI J 18:405","journal-title":"EXCLI J"},{"issue":"1","key":"11360_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.21859\/mci-01011","volume":"1","author":"S Nazem","year":"2017","unstructured":"Nazem S et al (2017) Protective effect of encapsulated nanocurcumin-PEGOA against oxidative damage on human mesenchymal stem cells exposed to hydroquinone as a risk factor for leukemia. Multidisciplinary Cancer Invest 1(1):3\u201310","journal-title":"Multidisciplinary Cancer Invest"},{"issue":"1","key":"11360_CR14","doi-asserted-by":"publisher","first-page":"e3911","DOI":"10.1002\/cbf.3911","volume":"42","author":"I Ahmad","year":"2024","unstructured":"Ahmad I et al (2024) Curcumin, its derivatives, and their nanoformulations: revolutionizing cancer treatment. Cell Biochem Funct 42(1):e3911","journal-title":"Cell Biochem Funct"},{"issue":"6","key":"11360_CR15","doi-asserted-by":"publisher","first-page":"e14193","DOI":"10.5812\/ijcm.14193","volume":"11","author":"Maryam Farhadi","year":"2018","unstructured":"Farhadi M et al (2018) The radioprotective effects of nano-curcumin against genotoxicity induced by iodine-131 in patients with differentiated thyroid carcinoma (DTC) by micronucleus assay. Int J Cancer Manage, 11(6) :e14193. https:\/\/doi.org\/10.5812\/ijcm.14193","journal-title":"Int J Cancer Manag"},{"key":"11360_CR16","doi-asserted-by":"publisher","first-page":"121622","DOI":"10.1016\/j.ijpharm.2022.121622","volume":"617","author":"L Farhoudi","year":"2022","unstructured":"Farhoudi L et al (2022) Polymeric nanomicelles of curcumin: potential applications in cancer. Int J Pharm 617:121622","journal-title":"Int J Pharm"},{"issue":"10","key":"11360_CR17","doi-asserted-by":"publisher","first-page":"e202200397","DOI":"10.1002\/cbdv.202200397","volume":"19","author":"H Emtiazi","year":"2022","unstructured":"Emtiazi H et al (2022) Comparative study of Nano-liposome and Nano-niosome for delivery of Achillea millefolium essential oils: Development, Optimization, characterization and their cytotoxicity effects on cancer cell lines and antibacterial activity. Chem Biodivers 19(10):e202200397","journal-title":"Chem Biodivers"},{"issue":"2","key":"11360_CR18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/ptr.6230","volume":"33","author":"A Saadipoor","year":"2019","unstructured":"Saadipoor A et al (2019) Randomized, double-blind, placebo\u2010controlled phase II trial of Nanocurcumin in prostate cancer patients undergoing radiotherapy. Phytother Res 33(2):370\u2013378","journal-title":"Phytother Res"},{"key":"11360_CR19","doi-asserted-by":"publisher","first-page":"100531","DOI":"10.1016\/j.hermed.2021.100531","volume":"31","author":"Z Bateni","year":"2022","unstructured":"Bateni Z et al (2022) Effects of nano-curcumin supplementation on oxidative stress, systemic inflammation, adiponectin, and NF-\u03baB in patients with metabolic syndrome: A randomized, double-blind clinical trial. J Herb Med 31:100531","journal-title":"J Herb Med"},{"issue":"8","key":"11360_CR20","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1007\/s12035-020-01922-5","volume":"57","author":"S Sahab-Negah","year":"2020","unstructured":"Sahab-Negah S et al (2020) Curcumin loaded in niosomal nanoparticles improved the anti-tumor effects of free curcumin on glioblastoma stem-like cells: an in vitro study. Mol Neurobiol 57(8):3391\u20133411","journal-title":"Mol Neurobiol"},{"issue":"5","key":"11360_CR21","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/nprot.2006.339","volume":"1","author":"NA Franken","year":"2006","unstructured":"Franken NA et al (2006) Clonogenic assay of cells in vitro. Nat Protoc 1(5):2315\u20132319","journal-title":"Nat Protoc"},{"issue":"2","key":"11360_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.otohns.2004.09.006","volume":"132","author":"A Khafif","year":"2005","unstructured":"Khafif A et al (2005) Curcumin: a new radio-sensitizer of squamous cell carcinoma cells. Otolaryngology\u2014Head Neck Surg 132(2):317\u2013321","journal-title":"Otolaryngology\u2014Head Neck Surg"},{"issue":"3","key":"11360_CR23","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/mnfr.201100270","volume":"56","author":"JH Kim","year":"2012","unstructured":"Kim JH et al (2012) Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-\u03baB and NF\u2010\u03baB\u2010regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis. Mol Nutr Food Res 56(3):454\u2013465","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"11360_CR24","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.ijrobp.2009.06.034","volume":"75","author":"SK Sandur","year":"2009","unstructured":"Sandur SK et al (2009) Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-\u03baB activity. Int J Radiation Oncology* Biology* Phys 75(2):534\u2013542","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"issue":"4","key":"11360_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1254\/jphs.12149FP","volume":"121","author":"Q Qiao","year":"2013","unstructured":"Qiao Q, Jiang Y, Li G (2013) Inhibition of the PI3K\/AKT-NF-\u03baB pathway with curcumin enhanced radiation-induced apoptosis in human burkitt\u2019s lymphoma. J Pharmacol Sci 121(4):247\u2013256","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"11360_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-60765-1","volume":"10","author":"K Schwarz","year":"2020","unstructured":"Schwarz K et al (2020) Modification of radiosensitivity by curcumin in human pancreatic cancer cell lines. Sci Rep 10(1):1\u201310","journal-title":"Sci Rep"},{"issue":"1","key":"11360_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/01635581.2016.1115527","volume":"68","author":"J Hejazi","year":"2016","unstructured":"Hejazi J et al (2016) Effect of Curcumin supplementation during radiotherapy on oxidative status of patients with prostate cancer: A double Blinded, Randomized, Placebo-Controlled study. Nutr Cancer 68(1):77\u201385","journal-title":"Nutr Cancer"},{"issue":"1","key":"11360_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12951-025-03113-7","volume":"23","author":"S Gressler","year":"2025","unstructured":"Gressler S et al (2025) A systematic review of nanocarriers used in medicine and beyond - definition and categorization framework. J Nanobiotechnol 23(1):90","journal-title":"J Nanobiotechnol"},{"key":"11360_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jconrel.2022.05.056","volume":"348","author":"H Ding","year":"2022","unstructured":"Ding H et al (2022) Preparation and application of pH-responsive drug delivery systems. J Control Release 348:206\u2013238","journal-title":"J Control Release"},{"issue":"1","key":"11360_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","volume":"14","author":"A Albanese","year":"2012","unstructured":"Albanese A, Tang PS, Chan WC (2012) The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 14(1):1\u201316","journal-title":"Annu Rev Biomed Eng"},{"issue":"1","key":"11360_CR31","doi-asserted-by":"publisher","first-page":"11134","DOI":"10.1038\/s41598-019-47553-2","volume":"9","author":"L Minafra","year":"2019","unstructured":"Minafra L et al (2019) Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells. Sci Rep 9(1):11134","journal-title":"Sci Rep"},{"issue":"6","key":"11360_CR32","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10565-016-9354-9","volume":"32","author":"B Soltani","year":"2016","unstructured":"Soltani B et al (2016) Curcumin confers protection to irradiated THP-1 cells while its nanoformulation sensitizes these cells via apoptosis induction. Cell Biol Toxicol 32(6):543\u2013561","journal-title":"Cell Biol Toxicol"},{"issue":"2","key":"11360_CR33","first-page":"63","volume":"4","author":"E Zendedel","year":"2019","unstructured":"Zendedel E et al (2019) Cytotoxic effects investigation of nanomicelle and free curcuminoids against cancer and normal cells. Nanomed Res J 4(2):63\u201368","journal-title":"Nanomed Res J"},{"issue":"1","key":"11360_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1667\/RR3255.1","volume":"180","author":"JL Ryan","year":"2013","unstructured":"Ryan JL et al (2013) Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of Thirty breast cancer patients. Radiat Res 180(1):34\u201343","journal-title":"Radiat Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11360-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11360-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11360-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T06:36:31Z","timestamp":1765434991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11360-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11360"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11360-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval for this study was granted under the code IR.MUMS.MEDICAL.REC.1399.344.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical approval"}}],"article-number":"190"}}